# Viz.Al, Inc.

- Location (FDA's records): San Francisco, CA
- FDA decisions: 1 (2018–2018): 1 De Novo grant
- Product codes: QAS (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 10 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Aidoc Medical, Ltd.: 2 (https://510kreport.com/company/aidoc-medical)
- Viz. Ai, Inc.: 2 (https://510kreport.com/company/viz-ai)
- Deep01 Limited: 1 (https://510kreport.com/company/deep01)
- Circle Neurovascular Imaging, Inc.: 1 (https://510kreport.com/company/circle-neurovascular-imaging)
- Curemetrix, Inc.: 1 (https://510kreport.com/company/curemetrix)
- Nico-Lab B.V.: 1 (https://510kreport.com/company/nico-lab)
- Methinks Software, S.L: 1 (https://510kreport.com/company/methinks-software-s-l)
- Maxq AL, Ltd.: 1 (https://510kreport.com/company/maxq-al)

## Its most-cited devices
- DEN170073: ContaCT (2018), cited by 10

## Recent decisions
- DEN170073: ContaCT (Feb 13, 2018)

Source page: https://510kreport.com/company/viz-al